Dr. Ranjeet Singh Mahla is an Oxford BMS Research Fellow at the Kennedy Institute of Rheumatology, University of Oxford. Currently, Dr. Mahla is supported by BMS-Celgene and EULAR grants to study autoreactive B cells in Sjögren’s disease (SjD) by performing scRNA-Seq (GEX + VDJ repertoire) analysis of salivary gland biopsies and autoantigen-reactive B cells in the blood. He holds a graduate degree in Chemistry, Botany, and Biotechnology; a Master's in Life Science; a PhD in Immunology; and a postgraduate qualification in AI and ML. His research interests span studying infectious diseases (tuberculosis, COVID-19) and vaccine development, autoimmunity (SLE, RA, SjD, MS), the tumor microenvironment and lymphoid structures, stem cell biology (germline stem cells, microfluidics, and organoid culture), and AI and ML. Dr. Mahla was a recipient of the Newton Bhabha PhD placement program in 2016-17 (placement at UCL, UK) and is an alumnus of the University of Rajasthan, DAVV Indore, CCMB Hyderabad, IISER Bhopal, and LJMU, UK. He also serves on the editorial board of The FASEB Journal. Dr. Mahla is deeply interested in applying deep learning algorithms to uncover disease-specific patterns and expression profiles from single-cell OMICS data and imaging datasets, aiming to advance the understanding of infectious and autoimmune disease biology.